For pharma, diagnosing what ails or strengthens performance in this critical corporate discipline may help reshape business prognosis.
Richard M. Bayney
Advertisement
Articles by Richard M. Bayney
Advertisement
Latest Updated Articles
Portfolio Management Health CheckPublished: May 12th 2017 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
5